Bruker Corporation
Description
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
About
CEO
Dr. Frank H. Laukien Ph.D.
Employees
9,707
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Devices
MIC code
XNGS
Address
40 Manning Road, Billerica, MA 01821, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 3, 2025 | — | — | — | — |
| Aug 4, 2025 | — | — | — | — |
| Apr 30, 2025 | — | — | — | — |
| Nov 5, 2024 | 0.59 | 0.60 | 0.01 | 1.69% |
| Aug 6, 2024 | 0.52 | 0.52 | 0.00 | 0.00% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 11 | — | 14 |
| Average estimate | — | 0.53 | — | 2.71 |
| Low estimate | — | 0.41 | — | 2.50 |
| High estimate | — | 0.60 | — | 2.94 |
| Last year EPS | — | 0.53 | — | 2.39 |
[stock_revenue_estimate]
Growth estimates
Current qtr
5.150%
Next qtr. (Mar 2025)
-0.270%
Current year
-7.530%
Next year (Dec 2025)
13.450%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 2.96B | 2.53B | 2.42B | 1.99B | 2.07B |
| Cost of revenue | 1.45B | 1.23B | 1.21B | 1.05B | 1.08B |
| Gross profit | 1.51B | 1.31B | 1.21B | 939.80M | 995.30M |
| Operating expense | |||||
| Research & development | 294.80M | 235.90M | 220.80M | 198.00M | 187.70M |
| Selling general and admin | 730.10M | 610.80M | 564.50M | 477.80M | 504.80M |
| Other operating expenses | 5.00M | 3.00M | 2.80M | 2.50M | 3.70M |
| Operating income | 488.40M | 459.00M | 424.30M | 264.00M | 302.80M |
| Non operating interest income | |||||
| Income | 11.20M | 4.10M | 900,000 | 3.20M | 1.30M |
| Expense | 16.40M | 16.10M | 14.30M | 14.40M | 16.00M |
| Other income expense | 61.00M | -33.10M | -17.30M | -27.00M | -7.70M |
| Pretax income | 544.20M | 413.90M | 393.60M | 225.80M | 280.40M |
| Tax provision | 117.70M | 116.40M | 113.00M | 64.40M | 82.40M |
| Net income | 428.50M | 298.50M | 280.60M | 161.40M | 198.00M |
| Basic EPS | 2.92 | 2.00 | 1.83 | 1.03 | 1.27 |
| Diluted EPS | 2.90 | 1.99 | 1.81 | 1.02 | 1.26 |
| Basic average shares | 146.40M | 148.60M | 151.40M | 153.40M | 155.20M |
| Diluted average shares | 146.40M | 148.60M | 151.40M | 153.40M | 155.20M |
| EBITDA | 604.20M | 548.10M | 511.50M | 345.10M | 376.00M |
| Net income from continuing op. | 428.50M | 298.50M | 280.60M | 161.40M | 198.00M |
| Minority interests | -1.30M | -1.90M | -3.50M | -3.60M | -800,000 |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 4.25B | 3.61B | 3.65B | 3.05B | 2.77B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 488.30M | 645.50M | 1.07B | 681.80M | 678.30M |
| Other short term investments | — | — | 100.00M | 50.00M | 6.60M |
| Accounts receivable | 492.00M | 472.70M | 416.90M | 335.30M | 362.20M |
| Other receivables | 83.90M | 60.80M | — | — | — |
| Inventory | 968.30M | 800.10M | 710.10M | 692.30M | 577.20M |
| Prepaid assets | 55.50M | 43.30M | — | — | — |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | 1.40M | 4.40M | — | — |
| Hedging assets | 12.00M | 14.80M | — | — | — |
| Other current assets | 18.30M | 12.80M | 172.20M | 165.60M | 172.00M |
| Non current assets | |||||
| Properties | 91.70M | 51.20M | 59.90M | 67.40M | 65.60M |
| Land and improvements | 38.90M | 36.60M | 34.10M | 36.50M | 26.50M |
| Machinery furniture equipment | 586.90M | 462.60M | 435.60M | 416.80M | 400.00M |
| Construction in progress | — | — | — | — | — |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -524.20M | -446.70M | -435.10M | -432.50M | -425.60M |
| Goodwill | 1.50B | 1.19B | 890.80M | 869.90M | 819.20M |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 330.50M | 270.90M | 211.80M | 229.10M | 233.20M |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 481.20M | 231.90M | 160.90M | 111.60M | 77.30M |
| Total liabilities | 2.84B | 2.48B | 2.57B | 2.07B | 1.83B |
| Current liabilities | |||||
| Accounts payable | 202.70M | 178.40M | 147.40M | 134.60M | 118.40M |
| Accrued expenses | 96.30M | 80.90M | 90.80M | 88.80M | 76.20M |
| Short term debt | 144.50M | 35.10M | 130.30M | 23.50M | 21.10M |
| Deferred revenue | 400.00M | 370.20M | 335.90M | 307.20M | 240.50M |
| Tax payable | 157.40M | 104.00M | 90.50M | 116.50M | 69.90M |
| Pensions | 166.50M | 136.10M | 132.00M | 110.60M | 105.70M |
| Other current liabilities | 34.70M | 9.60M | 11.60M | 10.70M | 13.80M |
| Non current liabilities | |||||
| Long term debt | 1.24B | 1.24B | 1.26B | 889.30M | 859.80M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | 67.70M | 62.30M | 46.00M | 43.10M | 48.80M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 163.60M | 120.80M | 162.20M | 176.10M | 113.90M |
| Shareholders equity | |||||
| Common stock | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M |
| Retained earnings | 2.32B | 1.93B | 1.66B | 1.41B | 1.27B |
| Other shareholders equity | 6.00M | 14.80M | -8.20M | 3.70M | -25.50M |
| Total shareholders equity | 1.41B | 1.13B | 1.08B | 974.30M | 938.20M |
| Additional paid in capital | 282.90M | 256.30M | 237.80M | 216.30M | 199.70M |
| Treasury stock | 1.24B | 1.09B | 820.30M | 667.00M | 543.80M |
| Minority interest | 36.10M | 18.00M | 14.30M | 13.10M | 31.40M |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | 428.50M | 298.50M | 280.60M | 161.40M | 198.00M | 181.00M | 80.30M | 154.50M | 104.90M | 59.60M | 81.80M | 78.20M | 94.00M | 96.80M | 81.00M | 65.20M | 98.90M | 18.48M | 9.75M | -3.86M | -17.55M | -6.80M | 2.69M | 2.25M | 1.25M |
| Depreciation | 114.90M | 88.80M | 89.10M | 80.40M | 75.60M | 64.90M | 63.90M | 54.30M | 53.30M | 59.70M | 61.30M | 59.10M | 52.90M | 36.10M | 29.70M | 29.30M | 27.90M | 13.29M | 10.51M | 11.20M | 10.38M | 11.82M | 8.92M | 4.15M | 3.49M |
| Deferred Taxes | -24.40M | -14.80M | -5.80M | -22.50M | -5.40M | -15.10M | 28.20M | -22.70M | -29.40M | -9.20M | 7.40M | -11.70M | -4.80M | -3.60M | -2.10M | -2.30M | -1.20M | 1.41M | -1.32M | 918,000 | 3.37M | -2.17M | -1.49M | -3.34M | — |
| Stock-Based Compensation | 24.00M | 27.70M | 17.20M | 16.00M | 9.60M | 11.30M | 11.00M | 9.40M | 8.00M | 9.40M | 6.60M | 7.80M | 7.90M | 6.90M | 6.30M | 4.50M | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | -118.80M | 26.80M | 28.00M | 27.30M | 10.10M | — | — | — | — | 2.70M | 2.10M | 4.90M | 1.20M | 1.90M | -200,000 | 4.20M | 2.80M | 1.11M | 183,000 | 3.39M | — | — | — | — | — |
| Accounts Receivable | -900,000 | -67.90M | -95.30M | 40.80M | -5.00M | -30.50M | -55.50M | -8.40M | 45.00M | -14.50M | -19.30M | 1.60M | -52.80M | -27.30M | -9.40M | 33.00M | -30.00M | -5.78M | -2.25M | -5.76M | 4.56M | -10.61M | -11.22M | 499,000 | -3.61M |
| Accounts Payable | 23.10M | 13.20M | 61.40M | -2.40M | 15.90M | 5.00M | 33.70M | -19.60M | 12.60M | 9.00M | 7.00M | 4.60M | 23.40M | 29.60M | 5.70M | -39.30M | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | -153.70M | -82.60M | -47.40M | -11.70M | -98.50M | -20.70M | -24.00M | -34.00M | -34.00M | -39.40M | -5.00M | -51.50M | -32.00M | -1.40M | 13.30M | 16.50M | 6.90M | 3.18M | 30.25M | -2.18M | -4.79M | -17.01M | -20.61M | -6.64M | -3.16M |
| Operating Cash Flow | 292.70M | 289.70M | 327.80M | 289.30M | 200.30M | 195.90M | 137.60M | 133.50M | 160.40M | 77.30M | 141.90M | 93.00M | 89.80M | 139.00M | 124.30M | 111.10M | 105.30M | 31.69M | 47.12M | 3.72M | -4.04M | -24.77M | -21.72M | -3.09M | -2.03M |
| Investing Activities | |||||||||||||||||||||||||
| Capital Expenditures | -95.80M | -115.30M | -87.10M | -97.00M | -62.00M | -48.80M | -32.20M | -36.00M | -33.30M | -30.70M | -48.90M | -69.50M | -54.40M | -29.20M | -16.30M | -47.40M | -26.20M | -7.62M | -4.79M | -10.05M | -5.49M | -28.77M | -20.03M | -5.58M | -4.24M |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | -226.60M | -182.30M | -65.00M | -59.20M | -90.00M | -191.60M | -66.30M | -24.30M | -28.40M | 21.40M | -11.10M | -23.70M | -14.30M | -269.80M | -1.90M | -11.40M | -8.30M | -26.45M | -5.61M | — | -5.50M | -867,000 | -6.24M | 22,000 | -200,000 |
| Purchase of Investments | -24.80M | -60.20M | -148.50M | -151.20M | -6.40M | — | -118.50M | -126.50M | -159.40M | -211.60M | — | — | — | — | — | -100,000 | -500,000 | — | -1.28M | -5.39M | -56.78M | -785,000 | -3.24M | -92.39M | — |
| Sale of Investments | 21.20M | 106.20M | 108.20M | 114.70M | — | 117.00M | 186.80M | 165.00M | 118.70M | 19.00M | — | — | — | — | — | 9.80M | 3.00M | 46.46M | — | 11.59M | 27.03M | 47.76M | 14.44M | — | — |
| Investing Cash Flow | -326.00M | -251.60M | -192.40M | -192.70M | -158.40M | -123.40M | -30.20M | -21.80M | -102.40M | -201.90M | -60.00M | -93.20M | -68.70M | -299.00M | -18.20M | -47.70M | -31.10M | 12.30M | -12.03M | -4.30M | -40.71M | 17.35M | -17.06M | -85.53M | -4.44M |
| Financing Activities | |||||||||||||||||||||||||
| Long-Term Debt Issuance | — | 300,000 | 490.50M | — | 597.90M | — | — | 146.00M | 42.00M | — | — | 240.00M | — | — | 1.60M | 199.20M | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | -21.50M | -111.00M | -800,000 | -305.80M | -381.50M | -222.90M | -150.90M | -100,000 | -130.10M | -800,000 | -1.60M | -299.70M | -29.30M | -21.60M | -86.30M | -26.20M | — | — | — | — | — | — | — | — | — |
| Other Financing Charges | 300,000 | -14.50M | -500,000 | -8.80M | -10.60M | -3.20M | -4.50M | 500,000 | -2.10M | -400,000 | 400,000 | -3.40M | -1.40M | -1.10M | -900,000 | -1.00M | — | -74.02M | — | — | -10.79M | -319,000 | 2.22M | — | — |
| Financing Cash Flow | -193.40M | -415.30M | 318.70M | -466.70M | -61.90M | -330.50M | -289.00M | 118.10M | -256.90M | 6.70M | 26.50M | -182.10M | 3.30M | 168.20M | -84.10M | -233.70M | -65.80M | -72.44M | 377,000 | 14.42M | -10.80M | 4.79M | 77.33M | 109.69M | — |
| Other Cash Details | |||||||||||||||||||||||||
| End Cash Position | 491.60M | 648.70M | 1.07B | 685.50M | 681.90M | 326.30M | 328.90M | 345.90M | 271.20M | 319.50M | 438.70M | 310.60M | 246.00M | 230.40M | 207.10M | 166.20M | 332.40M | 52.15M | 62.63M | 41.42M | 25.34M | 84.81M | 57.17M | 21.74M | 2.44M |
| Income Tax Paid | 96.60M | 147.40M | 145.50M | 43.00M | 61.30M | 60.50M | 53.10M | 72.40M | 56.60M | 55.90M | 84.30M | -79.90M | 69.70M | 38.70M | 54.20M | 38.70M | — | — | — | — | — | — | — | — | — |
| Interest Paid | 33.70M | 24.30M | 19.60M | 28.70M | 16.00M | 11.70M | 15.20M | 12.50M | 12.20M | 12.70M | 12.70M | -10.10M | 6.70M | 4.50M | 6.30M | 10.80M | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 243.20M | 145.20M | 190.40M | 235.00M | 140.40M | 190.50M | 110.70M | 93.70M | 195.00M | 80.50M | 94.70M | 60.30M | 26.10M | 124.20M | 133.50M | 59.50M | 81.40M | 30.07M | 44.93M | -4.37M | -11.60M | -39.49M | -33.63M | -5.78M | 1.20M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Price (T.Rowe) Mid Cap Growth Fund | Sep 30, 2024 | 4,488,600 | 253.11M | 2.96% |
| iShares Core S&P Midcap ETF | Nov 30, 2024 | 3,549,425 | 200.15M | 2.34% |
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 3,350,066 | 188.91M | 2.21% |
| Vanguard Small-Cap Index Fund | Sep 30, 2024 | 2,652,926 | 149.60M | 1.75% |
| MFS Series Trust X-MFS International Intrinsic Value Fund | Nov 30, 2024 | 2,280,413 | 128.59M | 1.50% |
| Fidelity OTC Portfolio | Nov 30, 2024 | 2,138,721 | 120.60M | 1.41% |
| Touchstone Funds Group Tr-Touchstone Mid-Cap Fd | Sep 30, 2024 | 1,752,362 | 98.82M | 1.16% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 1,632,395 | 92.05M | 1.08% |
| Fidelity Select Portfolios - Medical Technology & Devices Port | Nov 30, 2024 | 1,600,000 | 90.22M | 1.06% |
| Vanguard Small-Cap Growth Index Fund | Sep 30, 2024 | 1,462,879 | 82.49M | 0.96% |
Article
Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2024 Earnings Webcast” hyperlink in the “Events & Presentat.
Feb 7, 2025
Article
Bruker (BRKR) to Report Q4 Results: Wall Street Expects Earnings Growth
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Feb 4, 2025
Article
CALID Arm Growth to Support Bruker Shares Amid Macro Issues
BRKR's NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.
Jan 24, 2025
